Cystic fibrosis (CF) is a common recessive disorder with impaired vectorial transport across epithelial tissue. Over 750 mutations and 100 variations have been found in the affected gene and its product- the cystic fibrosis transmembrane conductance regulator (CFTR). The spectrum of the disease phenotype depends both on the nature of the mutation or combinations of mutations and on role of chloride transport and the regulatory properties of CFTR in individual epithelial tissues. A series of mutations that have been identified in patients that involve missense mutations in the first nucleotide binding fold (NBF1) or premature terminations in the carboxyl terminal region, will be used in model systems to understand the cellular machinery that participate in biogenesis and maintenance of CFTR at the cell surface. Preliminary data indicate that these mutations lead to diminished CFTR expression by two distinct mechanisms. Missense mutations in MBF1 accelerate the degradation of the immature CFTR at the endoplasmic reticulum. In contrast, premature termination at the C-terminal tail regions does not affect biosynthesis but leads to destabilization of mature CFTR.
The specific aims are to: 1) delineate the mechanism of mutations that show impaired biogenesis with features distinct from deltaF508CFTR, 2) elucidate the role of the carboxyl terminus in maintaining cell surface stability of CFTR, 3) identify the protein-protein interactions that participate in the recognition of the missense mutations or are critical in the maintenance of CFTR density at the cell surface. All aspects of biogenesis, routing and stability of CFTR must be understood and considered to design effective therapeutic strategies to control the symptoms of deficiencies in CF. This is notably challenging as it is readily evident that the biogenesis and routing of the multi-domain CFTR protein is a complex process involving a series of interactions and regulatory steps with rigorous quality control checks.

Project Start
1999-09-30
Project End
2000-08-31
Budget Start
Budget End
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Hospital for Sick Chldrn (Toronto)
Department
Type
DUNS #
208511808
City
Toronto
State
ON
Country
Canada
Zip Code
M5 1-X8
Vandivier, R William; Richens, Tiffany R; Horstmann, Sarah A et al. (2009) Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences. Am J Physiol Lung Cell Mol Physiol 297:L677-86
Wilschanski, Michael; Durie, Peter R (2007) Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 56:1153-63
Moraes, Theo J; Plumb, Jonathan; Martin, Raiza et al. (2006) Abnormalities in the pulmonary innate immune system in cystic fibrosis. Am J Respir Cell Mol Biol 34:364-74
Oh, Ray S; Bai, Xinli; Rommens, Johanna M (2006) Human homologs of Ubc6p ubiquitin-conjugating enzyme and phosphorylation of HsUbc6e in response to endoplasmic reticulum stress. J Biol Chem 281:21480-90
Wilschanski, Michael; Dupuis, Annie; Ellis, Lynda et al. (2006) Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Am J Respir Crit Care Med 174:787-94
Bishop, Michele D; Freedman, Steven D; Zielenski, Julian et al. (2005) The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum Genet 118:372-81
Mei-Zahav, M; Durie, P; Zielenski, J et al. (2005) The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants. Arch Dis Child 90:675-9
Durie, Peter R; Kent, Geraldine; Phillips, M James et al. (2004) Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol 164:1481-93
Gilljam, Marita; Moltyaner, Yuri; Downey, Gregory P et al. (2004) Airway inflammation and infection in congenital bilateral absence of the vas deferens. Am J Respir Crit Care Med 169:174-9
Gilljam, Marita; Ellis, Lynda; Corey, Mary et al. (2004) Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 126:1215-24

Showing the most recent 10 out of 30 publications